Sglt2 Inhibitor

Adults with type 2 diabetes may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to a study published in Nutrition, Metabolism & Cardiovascular Diseases.

Researchers identified transportation, natural gas and water to be the top contributors to emissions from hemodialysis centers, resulting in 58.9 kg carbon dioxide equivalents of emissions from a single center during 2020.

Initiation rates of GLP-1 receptor agonists and SGLT2 inhibitors among older adults with type 2 diabetes and atherosclerotic cardiovascular disease or congestive heart failure remained low from 2016 to 2019, according to study data.

Researchers found evidence that GLP-1 receptor agonists, but not SGLT2 inhibitors or DPP-IV inhibitors, may help prevent stroke for individuals with type 2 diabetes, according to results of a meta-analysis.

Treatment of HF has evolved rapidly in recent years, with novel therapies and a fundamentally new treatment algorithm offering options for improved management of the disease across the full spectrum of ejection fraction.

A phase 3 trial of empagliflozin demonstrated statistically significant HbA1c reduction among children and adolescents aged 10 to 17 years with type 2 diabetes, according to a press release from Eli Lilly.

Treatments for type 1 diabetes must be tailored to the heterogeneity of disease physiology among patients, moving beyond population-based HbA1c measures to individualized glycemic time in targets, according to a speaker.

Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased survival free of kidney failure if treated with the combination of angiotensin receptor blockers and SGLT2 inhibitors.

ORLANDO — In the 7 years since 2015, nephrologists have showed a 35-fold increased use of SGLT2 inhibitors, according to a presenter at ASN Kidney Week.

ORLANDO — SGLT2 inhibitors reduce the risk and progression of chronic kidney disease and AKI regardless of diabetes status, according to data presented at ASN Kidney Week.